CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Omnicell Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Omnicell Inc
4220 NORTH FREEWAY
Phone: (302) 636-5400p:302 636-5400 FORT WORTH, TX  76137  United States Ticker: OMCLOMCL

Business Summary
Omnicell, Inc. is a healthcare technology provider focused on autonomous medication management, by unifying automation and AI-enabled intelligence, optimized by expert services, to drive clinical and business outcomes that are helping to improve efficiency and enhance patient safety for healthcare facilities. The Company is focused on helping its customers define and deliver a medication management strategy designed for pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. It provides a range of points of care medication and supplies dispensing systems, including automated systems and offers advanced automation solutions, including robotics designed to automate work, streamline workflows, and reduce human error. It provides central pharmacy automation solutions for both medication dispensing and IV compounding and provides patient engagement solutions.
(Source: 6-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202512/31/2025YesYes-YesYes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President, Chief Executive Officer Randall A.Lipps 67 10/16/2002 9/1/1992
Chief Financial Officer, Executive Vice President BairdRadford 55 8/26/2025 8/26/2025
Chief Operating Officer, Executive Vice President NnamdiNjoku 48 10/7/2024 10/7/2024
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
MTS Medication Technologies, Inc. 2003 Gandy Boulevard North St. Petersburg FL United States
Ateb, Inc. 11125 Forest Pines Drive Raleigh NC United States
Aesynt, Inc. 500 Cranberry Woods Drive Cranberry Township PA United States
ReCept Pharmacy, LLC 1620 W. Northwest Highway Grapevine TX United States
MarkeTouch Media, Inc. 5718 Westheimer Road Houston TX United States

Business Names
Business Name
340B
Aesynt Holding Cooperatief U.A.
EnlivenHealth, Inc.
24 additional Business Names available in full report.

General Information
Number of Employees: 3,580 (As of 12/31/2025)
Outstanding Shares: 45,435,918 (As of 2/18/2026)
Shareholders: 68
Stock Exchange: NASD
Federal Tax Id: 943166458
Fax Number: (302) 636-5454
Email Address: info@Omnicell.com


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 12, 2026